Shanghai Children’s Medical Center (SCMC) has a planned bed capacity of 1,500, with 1,100 currently in use. Our team of 2,423 professionals includes 142 staff in standardized training, 57 research personnel, 987 nurses, 508 physicians, 349 medical technicians, 154 administrative staff, and 226 personnel in logistics, clerical work, and other professional technical roles.
SCMC is affiliated to Shanghai Jiao Tong University School of Medicine and is a tertiary A-level children’s hospital co-founded by the Shanghai Municipal People’s Government and Project HOPE. It officially opened in 1998. In 2017, the hospital was granted as National Children’s Medical Center, and the Zhangjiang Campus was officially launched in 2024.
Adhering to the mission of “All for Children”, the hospital leads all children’s hospitals nationwide in CMI, a metric reflecting the difficulty and severity of diseases treated. It has also consistently maintained Grade A in the national performance assessment for children's specialist hospitals. In 2018, it won the Shanghai Municipal Government Quality Gold Award. In 2022, it was selected as a pilot unit for the high-quality development of Shanghai’s public hospitals. It was also approved as a demonstration unit for Shanghai’s research ward development that year. In 2023, the hospital obtained qualifications for pediatric-to-adult care transition, heart transplantation, and neonatal metabolic screening, and was also designated as a pilot unit for self-developed LDT reagents. In 2024, the hospital was selected as a pilot unit for international medical tourism among Shanghai’s public hospitals and named a national characteristic construction unit for Integrated Maternal-Fetal Management for Fetal Heart Disease. In 2025, the hospital was approved for the national-level weight management center construction project and included in Shanghai’s first batch of child-friendly hospitals.
The hospital has successively assumed management of four national children’s regional medical centers, namely SCMC Fujian Hospital, SCMC Hainan Hospital, SCMC Guizhou Hospital and SCMC Linyi Hospital. It has also maintained close cooperation with 9 provincial-level regional medical centers, effectively promoting the extension of high-quality medical resources to grassroots areas.
The Lujiazui Campus is in the Lujiazui Financial and Trade Zone of Pudong New Area, covering an area of 93 mu (approximately 62,000 square meters) with a total construction area of 149,003 square meters. It has 1,000 beds and 26 operating rooms. Focusing on specialized fields such as the diagnosis and treatment of severe and complex diseases, and children’s health management, the campus provides comprehensive clinical specialist services covering the entire growth and development cycle of children. It is positioned to become a domestically leading and internationally renowned hub for pediatric medical treatment, as well as a highland for the research and development of innovative pediatric drugs and medical devices for children’s healthcare institutions in China.
The Zhangjiang Campus is located in the Shanghai International Medical Zone within Zhangjiang Science City, Pudong New Area, covering an area of 60 mu (approximately 40,000 square meters) with a total construction area of 99,799 square meters. It has 500 beds, 8 operating rooms, 32 bone marrow transplantation units, and houses China’s first pediatric radiotherapy center. Positioned as a children’s specialist medical institution with strong hematology-oncology specialties and refined comprehensive services, the campus also covers the diagnosis, treatment and health management of other common childhood diseases.
There are 8 National Key Clinical Specialties: Pediatric Critical Care, Pediatric Surgery, Pediatric Oncology, Pediatric Imaging, Pediatric Infectious Diseases, Pediatric Nutrition, Pediatric Cardiovascular Disorders, Pediatric Genetic Metabolism. And 3 National Key Disciplines: Cardiovascular Sciences, Hematology and Oncology, Developmental-Behavioral Pediatrics. It owns one National Key Laboratory: Key Laboratory of Pediatric Hematology and Oncology of the National Health Commission. The Cutting-Edge Research Bases include: Shanghai Institute of Pediatric Congenital Heart Disease; Shanghai Clinical Research Center for Children’s Rare Diseases; Shanghai Key Laboratory of Pediatric Clinical Molecular Diagnostics; Shanghai Key Laboratory of Child Brain and Intelligence Development; Shanghai Engineering Research Center of Virtual Reality for Structural Heart Disease; Institute of Pediatric Translational Medicine of Shanghai Jiao Tong University School of Medicine; Institute of Child Health Management of China Hospital Development Institute, Shanghai Jiao Tong University; and Institute of Health Social Work of China Hospital Development Institute, Shanghai Jiao Tong University.
SCMC also has some Sino-Foreign Joint Laboratories: SCMC-Boston Children’s Hospital Molecular Genetic Diagnosis Joint Laboratory, SCMC-St.Jude Children’s Research Hospital Joint Laboratory of Pediatric Oncology, and SCMC-BIOMÉRIEUX Joint Unit.
The hospital’s service capacity has continued to grow. In 2024, the total number of outpatient and emergency visits reached 2.121 million, with 1.384 million specialist outpatient visits. The number of inpatients stood at 54,132, including 28,166 inpatients who underwent surgery, of which 19,968 were grade III or IV surgeries. Since the Zhangjiang Campus was put into operation in 2024, it has completed over 300 hematopoietic stem cell transplants, ranking first in China in terms of both transplant disease types and total cases.
In 2025, the hospital secured 23 grants from the National Natural Science Foundation of China, ranking second among children’s hospitals nationwide. The research teams have published several original research findings in top-tier journals such as Circulation and Cell Death and Differentiation.
The hospital is among the first batch of Shanghai’s demonstration research-oriented wards, with 166 clinical research beds currently in use. In 2023, it was approved as the only children’s hospital nationwide to pilot self-developed reagents. In 2025, it completed the filing of its first in-hospital preparation “Qiling Jianpi Shufeng Granules” (a TCM formulation for invigorating the spleen and dispelling wind) and achieved the country’s first transaction of medical and health data assets in pediatrics.
As a National Civilized Unit, the hospital proactively undertakes social responsibilities. It took the lead in establishing a Medical Social Work Department in China in 1998, launched the first training program for pediatric medical staff in western and northeastern China in 2002, initiated the first “Belt and Road” assistance program in 2012 and started the first “Tear-Free Initiative” in 2014. In 2025, it signed a strategic cooperation agreement with Shanghai Mental Health Center to advance comprehensive and coordinated development focusing on mental health services for children and adolescents.
The hospital has established partnerships with over 30 medical institutions from more than 10 countries. In 2025, it signed a framework cooperation agreement with the University of Messina in Italy to build a pediatric university-hospital collaboration network, jointly promoting the development of Sino-Italian children’s health initiatives. The hospital also signed Letters of Intent with Singapore-based GITI Group and United in Diversity, collaborating to pursue joint initiatives focusing on international medical services, medical innovation and capacity development.
Website:https://www.scmc.com.cn/
